Mankind Pharma, India’s fourth largest pharmaceutical company, today announced a collaboration with OpenAI, a leading AI research and deployment company, to institutionalize AI across its value chain. As one of the first few Indian pharma companies to fully integrate advanced AI into core operations, Mankind aims to accelerate innovation and improve operational efficiency.

The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem. Mankind will integrate OpenAI Enterprise across multiple functions, including field force enablement, digital marketing, research and development (R&D), manufacturing, and medical affairs.

Speaking about this collaboration Arjun Juneja, Chief Operating Officer, Mankind Pharma Ltd. said "At Mankind Pharma, we see working with OpenAI as a pivotal step in building the pharma organization of the future. By integrating advanced AI into our core operations, we’re enabling our teams to move faster, work smarter, and unlock insights that drive real-world impact - whether it’s in field force effectiveness, supply chain agility, or R&D acceleration. This is not just about automation; it’s about creating a more responsive, intelligent, and future-ready enterprise. We’re excited to lead this shift in Indian pharma and set new benchmarks for how technology can drive both operational excellence and long-term value creation."

“Mankind Pharma’s company-wide adoption of ChatGPT Enterprise shows the practical role AI can play in regulated industries such as pharmaceuticals. By integrating advanced AI into areas like research, operations, and medical communications, Mankind is taking meaningful steps to improve efficiency and support innovation. We look forward to working with them in exploring how AI can be applied responsibly and safely to deliver value within their organization and across the healthcare ecosystem.” Oliver Jay, Managing Director, International at OpenAI.